OR WAIT null SECS
June 22, 2018
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
June 20, 2018
The company has resubmitted a biologics license application to FDA for its proposed biosimilar to Roche’s Herceptin.
The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.
The acquisition is expected to strengthen Roche’s personalized healthcare strategy.
June 19, 2018
Johnson & Johnson has accepted an offer from Platinum Equity to acquire diabetes solutions business LifeScan for $2.1 billion.
June 13, 2018
Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
WuXi Biologics will invest $60 Million to establish a biologics production facility in Massachusetts.
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
June 07, 2018
The company will provide the first FlexFactory manufacturing platform for cell therapy manufacturing.